Mendelian randomization studies, however, suggest that although elevated gal-3 concentrations serve as a marker of poor prognosis in CVDs, their causal role in the development of HF and vascular diseases remains uncertain [70,71]. This evidence concerns the gene LGALS3 and hydrops fetalis.